^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

zamtocabtagene autoleucel (MB-CART2019.1)

i
Associations
Company:
Miltenyi Biotec
Drug class:
CD19-targeted CAR-T immunotherapy, CD20-targeted CAR-T immunotherapy
Related drugs:
Associations